학술논문
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
Document Type
Article
Author
Source
In The Lancet Haematology January 2019 6(1):e12-e19
Subject
Language
ISSN
2352-3026